Broadfin Capital »

Biohaven Pharmaceutical Holding shares owned by Broadfin Capital

Quarter-by-quarter ownership of Biohaven Pharmaceutical Holding shares owned by Broadfin Capital from 13F filings

Historical chart of Broadfin Capital investment in Biohaven Pharmaceutical Holding

Tip: Access up to 7 years of quarterly data

All positions including Biohaven Pharmaceutical Holding held by Broadfin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven Pharmaceutical Holding by Broadfin Capital

Quarter filed Position value Share count Share price at filing
2019-12-31 $55M 1.0M 54.44
2019-09-30 $43M 1.0M 41.72
2019-06-30 $47M 1.1M 43.79
2019-03-31 $13M 247k 51.47
2018-12-31 $4.8M 129k 36.98

More positions owned by Broadfin Capital

Spdr S&p 500 Etf (SPY)
iShares Russell 2000 Index (IWM)
Biohaven Pharmaceutical Holding
SPDR S&P Biotech (XBI)
BioDelivery Sciences International
Alkermes (ALKS)
Viewray (VRAYQ)
Amarin Corporation (AMRN)
Quotient
Eiger Biopharmaceuticals
STAAR Surgical Company (STAA)
Intersect Ent
Progenics Pharmaceuticals
Nanostring Technologies (NSTGQ)
Iovance Biotherapeutics (IOVA)

View all positions for Broadfin Capital

Top funds holding Biohaven Pharmaceutical Holding

Knoll Capital Management
Birchview Capital
Brevan Howard Capital Management

View all funds holding Biohaven Pharmaceutical Holding